Tuesday 2 December 2003
In skeletal muscle, insulin resistance can result from high levels of circulating fatty acids that disrupt insulin signalling pathways. However, the severity of insulin resistance varies greatly among obese people.
This variability might reflect differences in levels of lipid-droplet proteins that promote the sequestration of fatty acids within adipocytes in the form of triglycerides, thereby lowering exposure of skeletal muscle to the inhibitory effects of fatty acids. (18401346)
Yki-Jarvinen H, Westerbacka J. The fatty liver and insulin resistance. Curr Mol Med. 2005 May;5(3):287-95. PMID: 15892648
Boden G, Hoeldtke RD. Nerves, fat, and insulin resistance. N Engl J Med. 2003 Nov 13;349(20):1966-7. PMID: 14614173
Cederberg A, Enerback S. Insulin resistance and type 2 diabetes—an adipocentric view. Curr Mol Med. 2003 Mar;3(2):107-25. PMID: 12630558